A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016)
一项 4 期开放标签研究,旨在评估 DTaP5-HBV-IPV-Hib 疫苗在先前接种过 DTaP2-HBV-IPV-Hib 或 DTaP5-HBV-IPV-Hib 疫苗的儿童中的安全性和免疫原性 (V419-016)
期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2024.2310900
Guerra, Andrea; Costantino, Claudio; Martinon-Torres, Federico; Westerholt, Soeren; Lambeth, Courtney; Chen, Ziqiang; Lumley, Jessie; Marcek, Tomas; Johnson, David; Wilck, Marissa